PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine

recombinant protective antigen (rPA) vaccine · Fraunhofer Center for Molecular Biotechnology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine, covering 2016-05-12 to 2016-05-12. Get the full timeline:

Most recent: Clinical Trial Update: PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine [Phase 1]

See pricing